Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Fmc Ip Technology GmbH is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners and are located within 2 distinct art units. This distribution shows that each pending matter is being handled by a different individual in a different technical group.
The busiest examiner, VISHNYAKOVA, ELENA VLADIMIROVNA, has 1 pending office action. This accounts for 1 of the 2 current pending actions, as the other action is with a different examiner. This indicates an even distribution of the workload across the assigned personnel.
The distribution across 2 art units indicates that the company's biotech and pharmaceutical filings are being reviewed by different specialized groups. Each of the 2 pending matters is being prosecuted independently, requiring the company to navigate two separate administrative environments at the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 68.3% | +46.6% |
| PATEL, SAGAR S | 1 | 75.6% | +35.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18834773 | METHODS FOR THE PREPARATION OF ETHYL 3-BROMO-1-(3-CHLOROPYRIDIN-2-YL)-4,5-DIHYDRO-1H-PYRAZOLE-5-CARBOXYLATE | VISHNYAKOVA, ELENA VLADIMIROVNA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18834773 | METHODS FOR THE PREPARATION OF ETHYL 3-BROMO-1-(3-CHLOROPYRIDIN-2-YL)-4,5-DIHYDRO-1H-PYRAZOLE-5-CARBOXYLATE | VISHNYAKOVA, ELENA VLADIMIROVNA | — |
| 18720258 | SOLID DIAMIDE AND BIFENTHRIN FORMULATION FOR CONTROLLING INVERTEBRATE PESTS | PATEL, SAGAR S | — |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18834773 | METHODS FOR THE PREPARATION OF ETHYL 3-BROMO-1-(3-CHLOROPYRIDIN-2-YL)-4,5-DIHYDRO-1H-PYRAZOLE-5-CARBOXYLATE | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §102§103§112 | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18720258 | SOLID DIAMIDE AND BIFENTHRIN FORMULATION FOR CONTROLLING INVERTEBRATE PESTS | PATEL, SAGAR S | 1626 | §103 | Non-Final OA | — | Pending | Jun 14, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFmc Ip Technology GmbH has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Elena Vladimirovna Vishnyakova has the most, with 1 of Fmc Ip Technology GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.